IOL CHEMICALS & PHARM. | ALPA LAB | IOL CHEMICALS & PHARM./ ALPA LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 11.2 | 122.6% | View Chart |
P/BV | x | 1.6 | 1.5 | 104.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ALPA LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ALPA LAB Mar-23 |
IOL CHEMICALS & PHARM./ ALPA LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 90 | 599.3% | |
Low | Rs | 272 | 49 | 556.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 44.2 | 854.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 6.0 | 396.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 6.6 | 477.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 64.0 | 401.5% | |
Shares outstanding (eoy) | m | 58.71 | 21.04 | 279.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.6 | 68.3% | |
Avg P/E ratio | x | 17.1 | 11.6 | 147.4% | |
P/CF ratio (eoy) | x | 12.8 | 10.5 | 122.4% | |
Price / Book Value ratio | x | 1.6 | 1.1 | 145.5% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,457 | 1,630.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 122 | 1,381.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 930 | 2,385.1% | |
Other income | Rs m | 256 | 94 | 273.4% | |
Total revenues | Rs m | 22,427 | 1,023 | 2,191.8% | |
Gross profit | Rs m | 2,257 | 81 | 2,794.7% | |
Depreciation | Rs m | 462 | 13 | 3,473.3% | |
Interest | Rs m | 165 | 2 | 7,352.7% | |
Profit before tax | Rs m | 1,887 | 159 | 1,187.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 33 | 1,496.7% | |
Profit after tax | Rs m | 1,391 | 126 | 1,105.8% | |
Gross profit margin | % | 10.2 | 8.7 | 117.2% | |
Effective tax rate | % | 26.2 | 20.8 | 126.1% | |
Net profit margin | % | 6.3 | 13.5 | 46.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,491 | 648.2% | |
Current liabilities | Rs m | 5,025 | 296 | 1,695.8% | |
Net working cap to sales | % | 20.9 | 128.6 | 16.3% | |
Current ratio | x | 1.9 | 5.0 | 38.2% | |
Inventory Days | Days | 43 | 326 | 13.3% | |
Debtors Days | Days | 8 | 1,835 | 0.5% | |
Net fixed assets | Rs m | 11,017 | 181 | 6,073.2% | |
Share capital | Rs m | 587 | 210 | 279.0% | |
"Free" reserves | Rs m | 14,490 | 1,135 | 1,276.2% | |
Net worth | Rs m | 15,077 | 1,346 | 1,120.3% | |
Long term debt | Rs m | 0 | 8 | 0.0% | |
Total assets | Rs m | 20,684 | 1,673 | 1,236.6% | |
Interest coverage | x | 12.5 | 71.9 | 17.3% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 192.9% | |
Return on assets | % | 7.5 | 7.7 | 98.3% | |
Return on equity | % | 9.2 | 9.3 | 98.7% | |
Return on capital | % | 13.6 | 11.9 | 114.3% | |
Exports to sales | % | 26.7 | 43.4 | 61.7% | |
Imports to sales | % | 0 | 4.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 403 | 1,471.1% | |
Imports (cif) | Rs m | NA | 43 | 0.0% | |
Fx inflow | Rs m | 5,930 | 403 | 1,471.1% | |
Fx outflow | Rs m | 6,052 | 46 | 13,099.1% | |
Net fx | Rs m | -122 | 357 | -34.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 89 | 1,373.2% | |
From Investments | Rs m | -1,200 | 21 | -5,639.1% | |
From Financial Activity | Rs m | -41 | -38 | 108.4% | |
Net Cashflow | Rs m | -18 | 72 | -25.4% |
Indian Promoters | % | 48.2 | 57.3 | 84.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.5 | 340.0% | |
FIIs | % | 1.4 | 0.5 | 280.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 42.7 | 121.3% | |
Shareholders | 130,003 | 18,690 | 695.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ALPA LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.71% | 0.89% | 1.03% |
1-Month | 6.55% | 12.12% | 1.10% |
1-Year | 1.45% | 55.82% | 53.75% |
3-Year CAGR | -12.66% | 12.50% | 14.67% |
5-Year CAGR | 16.39% | 30.34% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ALPA LAB share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ALPA LAB the stake stands at 57.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ALPA LAB.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ALPA LAB paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ALPA LAB.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.